case_images: PMC11706620_01
case_images: Gadolinium enhanced cardiac MRI during first in-patient episode
case_images: cureus-0017-00000077018-i01.jpg
case_images: PMC11706620_01_cureus-0017-00000077018-i01.jpg
case_images: FIG1
case_images: A cardiac MRI did not show any late gadolinium enhancement (Figure 1a, Figure 1b).
case_images: Invasive coronary angiogram.
case_images: cureus-0017-00000077018-i02.jpg
case_images: PMC11706620_01_cureus-0017-00000077018-i02.jpg
case_images: FIG2
case_images: Repeat gadolinium enhanced cardiac MRI
case_images: cureus-0017-00000077018-i03.jpg
case_images: PMC11706620_01_cureus-0017-00000077018-i03.jpg
case_images: FIG3
case_images: Again, this did not show any abnormalities, including late gadolinium enhancement (Figure 3a, Figure 3b). 
case_images: PET-CT images.
case_images: cureus-0017-00000077018-i04.jpg
case_images: PMC11706620_01_cureus-0017-00000077018-i04.jpg
case_images: FIG4
case_images: PET-CT was performed (Figure 4a, Figure 4b).
case_images: Results of the linearity experiment.
case_images: cureus-0017-00000077018-i05.jpg
case_images: PMC11706620_01_cureus-0017-00000077018-i05.jpg
case_images: FIG5
case_images: The linearity experiment showed that the troponin concentration diluted linearly in the sample, thereby excluding interference due to heterophilic antibodies, matrix effects, or prozone errors (Figure 5).